Page last updated: 2024-08-26

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and deferiprone

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with deferiprone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G1
Dekhordi, LS; Hider, RC; Jin, Y; Khodr, H; Liu, Z; Rai, BL1
Allen, DD; Fredenburg, AM; Sethi, RK; Yokel, RA1
Garbowski, M; Porter, J; Vlachodimitropoulou Koumoutsea, E1

Other Studies

4 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and deferiprone

ArticleYear
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship

1993
Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Journal of medicinal chemistry, 1998, Aug-27, Volume: 41, Issue:18

    Topics: Animals; Bile; Ferritins; Iron; Iron Chelating Agents; Male; Molecular Conformation; Pyridones; Rats; Rats, Inbred F344; Solutions; Structure-Activity Relationship

1998
The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat.
    Toxicology, 1996, Apr-30, Volume: 108, Issue:3

    Topics: Animals; Blood-Brain Barrier; Cerebral Ventricles; Chelating Agents; Deferiprone; Frontal Lobe; Iron Chelating Agents; Male; Microdialysis; Pyridones; Rats; Rats, Sprague-Dawley; Sodium Cyanide

1996
Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
    British journal of haematology, 2015, Volume: 170, Issue:6

    Topics: Benzoates; Cell Line; Deferasirox; Deferiprone; Deferoxamine; Drug Synergism; Humans; Intracellular Space; Iron; Iron Chelating Agents; Pyridones; Triazoles

2015